Avidity Partners Management »

Mestera shares owned by Avidity Partners Management

Quarter-by-quarter ownership of Mestera (MTSR) shares owned by Avidity Partners Management from 13F filings

Historical chart of Avidity Partners Management investment in Mestera

Tip: Access up to 7 years of quarterly data

All positions including Mestera held by Avidity Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mestera by Avidity Partners Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.4M 141k 52.33

More positions owned by Avidity Partners Management

Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Medtronic SHS (MDT)
Boston Scientific Corporation (BSX)
Oruka Therapeutics (ORKA)
Bristol Myers Squibb (BMY)
Natera (NTRA)
Danaher Corporation (DHR)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Perspective Therapeutics Com New (CATX)
Jade Biosciences Com New (JBIO)
Pfizer (PFE)
Thermo Fisher Scientific (TMO)
Context Therapeutics (CNTX)
Genmab A/s Sponsored Ads (GMAB)

View all positions for Avidity Partners Management

Top funds holding Mestera

FMR
Vanguard Group
Henderson Group
BlackRock
Alphabet
VR Adviser
Wellington Management Company
Softbank Group Corp
State Street Corporation
Falcon Edge Capital
T. Rowe Price Investment Management
Geode Capital Management
RA Capital Management
Susquehanna International
Charles Schwab Investment Management

View all funds holding Mestera